Literature DB >> 15180262

Mouse models of human retinal disease caused by expression of mutant rhodopsin. A valuable tool for the assessment of novel gene therapies.

May Nour1, Muna I Naash.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 15180262     DOI： 10.1007/978-1-4615-0067-4_22

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

2.  Light/dark translocation of alphatransducin in mouse photoreceptor cells expressing G90D mutant opsin.

Authors:  Zack A Nash; Muna I Naash
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

3.  In vitro analysis of ribozyme-mediated knockdown of an ADRP associated rhodopsin mutation.

Authors:  Dibyendu Chakraborty; Patrick Whalen; Alfred S Lewin; Muna I Naash
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

4.  Cone survival despite rod degeneration in XOPS-mCFP transgenic zebrafish.

Authors:  Ann C Morris; Eric H Schroeter; Joseph Bilotta; Rachel O L Wong; James M Fadool
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-12       Impact factor: 4.799

5.  The F220C and F45L rhodopsin mutations identified in retinitis pigmentosa patients do not cause pathology in mice.

Authors:  Tylor R Lewis; Camilla R Shores; Martha A Cady; Ying Hao; Vadim Y Arshavsky; Marie E Burns
Journal:  Sci Rep       Date:  2020-05-05       Impact factor: 4.996
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.